Dr. Baranwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
104 NW 31st St
Lawton, OK 73505Phone+1 580-536-2121
Education & Training
Cook County Health and Hospitals SystemFellowship, Hematology and Medical Oncology, 2018
Loyola Medicine MacNeal HospitalResidency, Internal Medicine, 2015 - 2018
G.S.V.M Medical College KanpurClass of 2013
Certifications & Licensure
OK State Medical License 2022 - 2025
IL State Medical License 2015 - 2023
MN State Medical License 2021 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsFeatures and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy.Mark Gurney, Anmol Baranwal, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Saad S Kenderian
JAMA Oncology. 2024-04-01 - 11 citationsRole of Germline Predisposition to Therapy-Related Myeloid Neoplasms.Anmol Baranwal, Christopher N Hahn, Mithun Vinod Shah, Devendra K Hiwase
Current Hematologic Malignancy Reports. 2022-12-01 - 7 citationsOutcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.Mithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, Chung H Kok, Naseema Gangat
American Journal of Hematology. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
